Linde (ETR:LIN) Stock Upgrade
Researchers at the Bernstein Research stock research division boosted shares of Linde (ETR:LIN) to a “Outperform” on 14 December. Bernstein Research currently has a price target of EUR 167.00 on LIN or 27.97% more upside.
From a total of 3 analysts covering Linde (ETR:LIN) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that NaN of the ratings are positive. The highest target price is €28 while the lowest target price is €26. The mean of all analyst targets is €27 with a 35.55% above today’s (€130.35) stock price. Linde was the topic of 53 analyst reports since July 17, 2015 according to the firm StockzIntelligence Inc. Societe Generale upgraded shares on December 9 to “Buy” rating. UBS downgraded shares to “Sell” rating and €135 target share price in a report from a December 2. Baader Wertpapierhandelsbank upgraded LIN stock in a recent report from December 9 to “Buy” rating. Warburg Research upgraded the rating on December 2. Warburg Research has a “Buy” rating and a €160 price target on shares. Finally, JP Morgan maintained the stock with “Neutral” rating in a report issued on a December 3.
The stock decreased 2.76% or EUR 3.7 on December 11, striking EUR 130.35. Approximately 819,818 shares of stock traded hands or 14.62% up from the average. Linde AG (ETR:LIN) has risen 1.50% since May 23, 2014 and is uptrending. It has outperformed by 5.92% the S&P500.
Linde AG is a Germany-based company engaged in the gas and engineering sectors. The company has a market cap of 24.05 billion EUR. It operates three divisions: Gases; Engineering , as well as Gist. It has 21.24 P/E ratio. The Gases Division includes Healthcare, producing medical gases; and Tonnage, as its two global business units; as well as the two business areas Merchant and Packaged Gases, offering liquefied and cylinder gases, and Electronics.